Nervonik raised a $52.5 million Series B to advance its peripheral nerve stimulation therapy.
- Amount
- $52.5M
- Stage
- Series B
- Announced
- 27 April 2026
- Lead
- Amzak Health
- Other investors
- Elevage Medical Technologies, U.S. Venture Partners (USVP), Lumira Ventures, Foothill Ventures, Shangbay Capital
- Use of funds
- Continued development and commercialization of its PNS system, including further development of proprietary sensing capabilities.
- Checked
- Amount and date checked against the press source